阿尔茨海默氏症的Aβ通过早期纳米集群溶解化催化了Tau相分离和聚合
Xun Sun1, Yiming Tang2,3, Xue Wang1
1Center for Life Sciences, Paul Scherrer Institute, Villigen PSI, Switzerland.
Nature communications
|March 11, 2026
概括
胺β (Aβ) 通过促进有毒tau凝结物的形成,增强阿尔茨海默病中tau蛋白的聚合. 这种相互作用加速了疾病病理和神经毒性.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默氏病 (AD) 的特征是粉样β (Aβ) 斑块和高化的神经纤维状结 (NFTs).
- 在生物分子凝聚物中Aβ和Tau之间的相互作用尚未得到充分理解.
研究的目的:
- 研究生物分子凝聚物内Aβ和Tau相互作用的机制.
- 阐明Aβ如何影响Tau相分离和聚合.
主要方法:
- 在体外相位分离试验.
- 陶凝结物的生物化学特征.
- 分子动力学模拟.分子动力学模拟.
主要成果:
- 虽然Aβ40不经历液-液相分离 (LLPS),但增强了Tau相分离.
- Aβ40被招募到Tau凝聚物中,改变它们的性质并加速成熟.
- Aβ40促进tau纤维化,增加细胞毒性,并最初溶解tau纳米集群.
结论:
- Aβ作为Tau凝聚和纤维化的催化剂.
- 早期的Aβ-Tau相互作用,由Tau重复域介导,促进病原性聚合.
- 了解这种相互作用对于开发AD疗法至关重要.
相关概念视频
Amyloid Fibrils
12.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.5K
Amyloid Fibrils
6.9K
6.9K


